The AI agent space in healthcare is crowded, and getting busier by the day. This is a good thing in many ways – but also a problem, especially…
Read more: Payors are blocking AI agent calls. What does that mean for Infinitus?
Resource center
Featured resource
Inside the future of patient engagement
Healthcare leaders from Pfizer, AbbVie, Optum RX, Amazon Pharmacy, and more share where AI is already working in patient support and where the industry still has work to do..
For all the talk of transformation and possibility, this moment actually feels like an inflection point for patient access and support. That…
Read more: Getting AI right in patient support: Takeaways from Infinitus and Novartis on stage
For patients starting a new therapy, speed matters. Delays in access aren’t just logistical issues; they’re barriers that can jeopardize outcomes…
Read more: How Amgen uses Infinitus to support patient access and reimbursement
Pharma’s shift to direct-to-patient (DTP) models is transforming how patients discover, access, and stay on the therapies they need. Today, Infinitus…
NOTE: This post is an excerpt of our ebook The agentic AI workforce is coming to healthcare. Click here to access the full publication. AI will…
Read more: How to rethink the healthcare workforce in the age of AI
When the ball drops on New Year’s Eve, most people are counting down to a fresh start. But for many patients, that countdown comes with a different…
For years, technical interviews have relied heavily on LeetCode-style problems: algorithms, data structures, and whiteboard puzzles. While these…
Read more: Beyond LeetCode: Interviewing for real engineering impact
This month, the Infinitus team focused on two major prior authorization (PA) bottlenecks, saving you time and helping you get patients on therapy…
NOTE: This post is adapted from Understanding the unmet support needs of patients, our survey of 500 patients with chronic illnesses, intended…
Read more: 46% of patients experience treatment delays, and more takeaways from our exclusive survey
